HRT pills raise risk of suffering a deadly blood clot, say experts
WOMEN who take hormone replacement therapy tablets are at a higher risk of developing potentially deadly blood clots, a study revealed yesterday. (Source: Daily Express - Health)
Source: Daily Express - Health - January 10, 2019 Category: Consumer Health News Source Type: news
Transdermal HRT Not Linked to Increased Risk for VTE
THURSDAY, Jan. 10, 2019 -- Oral hormone replacement therapy (HRT) is associated with an increased risk for venous thromboembolism (VTE), while transdermal preparations are not linked to increased risk, according to a study published online Jan. 9 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 10, 2019 Category: Pharmaceuticals Source Type: news
Will hormone replacement therapy end my feeling of dread?
Since I stopped taking hormone replacement therapy (HRT) eight years ago, I ’ve been waking up with this peculiar feeling of dread. Should I go back on HRT? I am 66 years old. (Source: the Mail online | Health)
Source: the Mail online | Health - December 9, 2018 Category: Consumer Health News Source Type: news
Will hormone replacement therapy end my feeling of dread?
Since I stopped taking hormone replacement therapy (HRT) eight years ago, I’ve been waking up with this peculiar feeling of dread. Should I go back on HRT? I am 66 years old. (Source: the Mail online | Health)
Source: the Mail online | Health - December 9, 2018 Category: Consumer Health News Source Type: news
Mayo-led study: Drug reduces hot flashes, improves breast cancer survivor quality of life
(Mayo Clinic) Research led by oncologists Roberto Leon-Ferre, M.D. and Charles Loprinzi, M.D. of Mayo Clinic has found that the drug oxybutynin helps to reduce the frequency and intensity of hot flashes in women who are unable to take hormone replacement therapy, including breast cancer survivors. These findings were presented at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 7, 2018 Category: International Medicine & Public Health Source Type: news
Oxybutynin lessens hot flash frequency, improves breast cancer survivor quality of life, Mayo-led study finds
SAN ANTONIO ? Research led by oncologists Roberto Leon-Ferre, M.D. and Charles Loprinzi, M.D. of Mayo Clinic has found that the drug oxybutynin helps to reduce the frequency and intensity of hot flashes in women who are unable to take hormone replacement therapy, including breast cancer survivors. These findings were presented at the 2018 San [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - December 7, 2018 Category: Research Source Type: news
Trauma May Increase CVD Risk for Lesbian, Bisexual Women Trauma May Increase CVD Risk for Lesbian, Bisexual Women
Although HIV and hormone replacement therapy are known to increase cardiovascular risk in certain LGBT populations, far less is understood about CVD risk factors in sexual minority women.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 8, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news
World Menopause Day
18 October 2018 is World Menopause Day and October is World Menopause Month.Cochrane Gynaecology and Fertility Group has published multiple reviews assessing the effectiveness and safety of interventions in menopausal women, including peri and postmenopausal women. To celebrate World Menopause Day we have collated a special selection of reviews investigating various treatments for menopausal symptoms such as hormone therapy, tibolone, relaxation, exercise, and alternative therapy.Black cohosh (Cimicifuga spp.) for menopausal symptomsDehydroepiandrosterone for women in the peri- or postmenopausal phaseHormone therapy f...
Source: Cochrane News and Events - October 18, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news
World Menopause Month
To raise awareness of health and menopause, the World Health Organisation and the International Menopause Society have designated October as World Menopause Month and 18 October 2019 as World Menopause Day. Cochrane Gynaecology and Fertility Group has published multiple reviews assessing the effectiveness and safety of interventions in menopausal women, including peri and postmenopausal women. To celebrate World Menopause Month and Day, we have collated a selection of reviews investigating various treatments for menopausal symptoms such as hormone therapy, tibolone, relaxation, exercise, and alternative therapy.Black c...
Source: Cochrane News and Events - October 18, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news
These 6 Habits May Reduce Your Risk of Breast Cancer
Breast cancer is the most prevalent cancer in the U.S., affecting almost 85 of every 100,000 Americans, according to recent data from the World Health Organization’s International Agency for Research on Cancer (IARC). Around the globe, 627,000 people are projected to die from breast cancer this year alone.
The silver lining is that with early detection and proper care, breast cancer is among the most treatable forms of the disease. In the U.S., breast cancer deaths dropped by 40% between 1989 and 2015, thanks to better screening and access to care — but a large body of research suggests that widespread adoption...
Source: TIME: Health - October 1, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized breast cancer news Source Type: news
Mediterranean Diet Tied to Lowered Stroke Risk for Women (CME/CE)
(MedPage Today) -- Drop in risk occurred regardless of menopausal status or hormone replacement therapy (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 20, 2018 Category: Cardiology Source Type: news
What is the truth on hormone replacement therapy?
Ever since a report by a U.S. study claimed in 2002 that it carried a significant risk of breast cancer and heart disease, most menopausal women remain scared of taking it. (Source: the Mail online | Health)
Source: the Mail online | Health - September 4, 2018 Category: Consumer Health News Source Type: news
Starting HRT in early fifties 'unlikely to cause cognitive decline'
Hormone replacement therapy (HRT) is not associated with cognitive decline when women have recently started the menopause or do not have diabetes, according to US researchers. (Source: Nursing Times)
Source: Nursing Times - July 30, 2018 Category: Nursing Source Type: news
Housecall: Menopause and hormone therapy
THIS WEEK'S TOP STORIES Hormone therapy: Is it right for you??? Hormone replacement therapy ? medications containing female hormones to replace the ones the body no longer makes after menopause ? is sometimes used to treat common menopausal symptoms, including hot flashes and vaginal discomfort. Hormone therapy also has been proven to prevent bone loss [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 30, 2018 Category: Databases & Libraries Source Type: news
